These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 26994005

  • 1. Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis.
    Bergman A, Qureshi AR, Haarhaus M, Lindholm B, Barany P, Heimburger O, Stenvinkel P, Anderstam B.
    J Nephrol; 2017 Apr; 30(2):255-262. PubMed ID: 26994005
    [Abstract] [Full Text] [Related]

  • 2. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
    Ray S, Beatrice AM, Ghosh A, Pramanik S, Bhattacharjee R, Ghosh S, Raychaudhury A, Mukhopadhyay S, Chowdhury S.
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.
    Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Obi Y, Rhee CM, Streja E, Yamagata K, Kalantar-Zadeh K, Kovesdy CP.
    Nephrol Dial Transplant; 2018 Feb 01; 33(2):264-273. PubMed ID: 28064159
    [Abstract] [Full Text] [Related]

  • 4. Determinants of bone mineral density in patients on haemodialysis or peritoneal dialysis--a cross-sectional, longitudinal study.
    Nybo M, Jespersen B, Aarup M, Ejersted C, Hermann AP, Brixen K.
    Biochem Med (Zagreb); 2013 Feb 01; 23(3):342-50. PubMed ID: 24266305
    [Abstract] [Full Text] [Related]

  • 5. Increased serum alkaline phosphatase levels correlate with high disease activity and low bone mineral density in patients with axial spondyloarthritis.
    Kang KY, Hong YS, Park SH, Ju JH.
    Semin Arthritis Rheum; 2015 Oct 01; 45(2):202-7. PubMed ID: 25895696
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease.
    Haarhaus M, Fernström A, Magnusson M, Magnusson P.
    Nephrol Dial Transplant; 2009 Nov 01; 24(11):3382-9. PubMed ID: 19542194
    [Abstract] [Full Text] [Related]

  • 7. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M, Monier-Faugere MC, Magnusson P, Malluche HH.
    Am J Kidney Dis; 2015 Jul 01; 66(1):99-105. PubMed ID: 25843703
    [Abstract] [Full Text] [Related]

  • 8. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).
    Manghat P, Souleimanova I, Cheung J, Wierzbicki AS, Harrington DJ, Shearer MJ, Chowienczyk P, Fogelman I, Nerlander M, Goldsmith D, Hampson G.
    Bone; 2011 May 01; 48(5):1127-32. PubMed ID: 21281749
    [Abstract] [Full Text] [Related]

  • 9. Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.
    Yavropoulou MP, Vaios V, Pikilidou M, Chryssogonidis I, Sachinidou M, Tournis S, Makris K, Kotsa K, Daniilidis M, Haritanti A, Liakopoulos V.
    J Clin Densitom; 2017 May 01; 20(4):490-497. PubMed ID: 28039046
    [Abstract] [Full Text] [Related]

  • 10. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D, Sankaralingam A, Scully P, Manghat P, Goldsmith D, Hampson G.
    Clin Biochem; 2013 Oct 01; 46(15):1405-9. PubMed ID: 23830844
    [Abstract] [Full Text] [Related]

  • 11. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.
    Kovesdy CP, Ureche V, Lu JL, Kalantar-Zadeh K.
    Nephrol Dial Transplant; 2010 Sep 01; 25(9):3003-11. PubMed ID: 20299338
    [Abstract] [Full Text] [Related]

  • 12. High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: bone histomorphometric analysis.
    Lobão R, Carvalho AB, Cuppari L, Ventura R, Lazaretti-Castro M, Jorgetti V, Vieira JG, Cendoroglo M, Draibe SA.
    Clin Nephrol; 2004 Dec 01; 62(6):432-9. PubMed ID: 15630902
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density, its predictors, and outcomes in peritoneal dialysis patients.
    Grzegorzewska AE, Młot-Michalska M.
    Adv Perit Dial; 2011 Dec 01; 27():140-5. PubMed ID: 22073846
    [Abstract] [Full Text] [Related]

  • 14. [Value of serum alkaline phosphatase for predicting 2-year fracture in patients with chronic kidney disease on dialysis].
    Pan J, Hu H, Zhang W, Chen J, Dou X.
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Aug 30; 38(9):1095-1099. PubMed ID: 30377117
    [Abstract] [Full Text] [Related]

  • 15. Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients.
    Park JC, Kovesdy CP, Duong U, Streja E, Rambod M, Nissenson AR, Sprague SM, Kalantar-Zadeh K.
    Hemodial Int; 2010 Apr 30; 14(2):182-92. PubMed ID: 20345388
    [Abstract] [Full Text] [Related]

  • 16. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.
    Rhee CM, Molnar MZ, Lau WL, Ravel V, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K.
    Perit Dial Int; 2014 Apr 30; 34(7):732-48. PubMed ID: 24385335
    [Abstract] [Full Text] [Related]

  • 17. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.
    Magnusson P, Sharp CA, Magnusson M, Risteli J, Davie MW, Larsson L.
    Kidney Int; 2001 Jul 30; 60(1):257-65. PubMed ID: 11422759
    [Abstract] [Full Text] [Related]

  • 18. Clinical usefulness of bone alkaline phosphatase in osteoporosis.
    Kyd PA, Vooght KD, Kerkhoff F, Thomas E, Fairney A.
    Ann Clin Biochem; 1998 Nov 30; 35 ( Pt 6)():717-25. PubMed ID: 9838984
    [Abstract] [Full Text] [Related]

  • 19. The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease.
    Haarhaus M, Fernström A, Qureshi AR, Magnusson P.
    Nutrients; 2021 Dec 09; 13(12):. PubMed ID: 34959954
    [Abstract] [Full Text] [Related]

  • 20. Clinical observations with a new specific assay for bone alkaline phosphatase: a cross-sectional study in osteoporotic and pagetic subjects and a longitudinal evaluation of the response to ovariectomy, estrogens, and bisphosphonates.
    Pedrazzoni M, Alfano FS, Girasole G, Giuliani N, Fantuzzi M, Gatti C, Campanini C, Passeri M.
    Calcif Tissue Int; 1996 Nov 09; 59(5):334-8. PubMed ID: 8849398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.